Literature DB >> 9836614

Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.

R Gastpar1, M Goldbrunner, D Marko, E von Angerer.   

Abstract

The aim of this study was the identification of the essential structural elements in the 12-formyl-5,6-dihydroindolo[2, 1-a]isoquinoline system required for the inhibition of tubulin polymerization which is understood to be the predominant mode of action of this class of cytostatics. Since 2-phenylindole forms the main fragment of this tetracycle, it was used as the basic structure and modified with respect to the number and positions of the oxygen functions in the aromatic rings. Further modifications related to the nitrogen, which was both replaced by oxygen and sulfur and alkylated. All derivatives were tested for cytostatic activity in human breast cancer cells (MDA-MB 231, MCF-7) and inhibition of tubulin polymerization. The spectrum of activity ranged from inactive to IC50 values of 35 nM (cell growth inhibition) and 1.5 microM (tubulin polymerization), respectively, for the most active derivative 3e (3-formyl-6-methoxy-2-(4-methoxyphenyl)indole). Although the correlation between antiproliferative activity and inhibition of tubulin polymerization was not very pronounced, all of the potent cytostatic agents in this study disrupted microtubule assembly completely at the standard concentration of 40 microM. By fluorescence microscopy it was demonstrated that the derivative 3e degrades the cytoskeleton in a similar fashion as colchicine does leading to the condensation of the microtubules around the nucleus after treatment. The comparison between hydroxy and methoxy derivatives revealed a striking difference between the 2-phenylindole derivatives and the indoloisoquinolines. In the 2-phenylindole series, the methoxy compounds were much more effective than the free phenols, whereas in the tetracyclic system the effect of the hydroxy derivatives exceeded that of the methylated compounds by 1 order of magnitude. Preliminary studies on the binding mode showed that both the 2-phenylindole derivatives and the indoloisoquinolines bind to the colchicine site on tubulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836614     DOI: 10.1021/jm980228l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.

Authors:  Mallinath B Hadimani; Matthew T Macdonough; Anjan Ghatak; Tracy E Strecker; Ramona Lopez; Madhavi Sriram; Benson L Nguyen; John J Hall; Raymond J Kessler; Anupama R Shirali; Li Liu; Charles M Garner; George R Pettit; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2013-09-09       Impact factor: 4.050

2.  Photochemical synthesis and anticancer activity of barbituric acid, thiobarbituric acid, thiosemicarbazide, and isoniazid linked to 2-phenyl indole derivatives.

Authors:  S Vijaya Laxmi; G Rajitha; B Rajitha; Asha Jyothi Rao
Journal:  J Chem Biol       Date:  2015-11-17

3.  Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway.

Authors:  Gowdahalli Krishnegowda; A S Prakasha Gowda; Hephzibah Rani S Tagaram; Kevin F Staveley-O' Carroll; Rosalyn B Irby; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2011-08-26       Impact factor: 3.641

4.  An efficient solvent-free synthesis of 2-(alkylamino)-2-oxo-1-arylethyl-6,12-dioxo-6,12-dihydroindolo[1,2-b]isoquinoline-11-carboxylate derivatives via four-component reaction.

Authors:  Tahmineh Kenarkoohi; Abbas Rahmati
Journal:  Mol Divers       Date:  2019-01-05       Impact factor: 2.943

Review 5.  Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.

Authors:  Prashant S Auti; Ginson George; Atish T Paul
Journal:  RSC Adv       Date:  2020-11-12       Impact factor: 4.036

6.  Ru-catalysed C-H arylation of indoles and pyrroles with boronic acids: scope and mechanistic studies.

Authors:  Carina Sollert; Karthik Devaraj; Andreas Orthaber; Paul J Gates; Lukasz T Pilarski
Journal:  Chemistry       Date:  2015-02-17       Impact factor: 5.236

7.  Synthesis, Biological Evaluation and Molecular Docking of Novel Indole-Aminoquinazoline Hybrids for Anticancer Properties.

Authors:  Malose J Mphahlele; Mmakwena M Mmonwa; Abimbola Aro; Lyndy J McGaw; Yee Siew Choong
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

8.  S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.

Authors:  Chao Zhang; Na Yang; Chun-Hao Yang; Hua-Sheng Ding; Cheng Luo; Yu Zhang; Mao-Jiang Wu; Xiong-Wen Zhang; Xu Shen; Hua-Liang Jiang; Ling-Hua Meng; Jian Ding
Journal:  PLoS One       Date:  2009-03-18       Impact factor: 3.240

9.  Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds.

Authors:  Carly Griffin; Jerald Nair; James McNulty; Siyaram Pandey; Natasha Sharda; Divya Sood
Journal:  Cancer Cell Int       Date:  2007-06-05       Impact factor: 5.722

10.  Synthesis and Evaluation of N-(3-Trifluoroacetyl-indol-7-yl) Acetamides for Potential In Vitro Antiplasmodial Properties.

Authors:  Malose J Mphahlele; Mmakwena M Mmonwa; Yee Siew Choong
Journal:  Molecules       Date:  2017-07-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.